The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Porcilis APP suspension for injection for pigs

Intervet Ireland LimitedVPA10996/100/001

Main Information

Trade NamePorcilis APP suspension for injection for pigs
Active SubstancesConcentrate of actinobacillus pleuropneumoniae antigens containing
Omp (outer membrane protein)
Apxi (105 kilodalton type i toxoid)
Apxii (105 kilodalton type ii toxoid)
Apxiii (120 kilodalton macrophage toxoid)
Dosage FormSuspension for injection
Licence HolderIntervet Ireland Limited
Licence NumberVPA10996/100/001

Group Information

ATC CodeQI09AB07 actinobacillus/haemophilus vaccine
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued31/01/2014
Legal StatusPOM (E): Prescription Only Exempt as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back